MY171853A - Sphingomyelin-containing supplement - Google Patents

Sphingomyelin-containing supplement

Info

Publication number
MY171853A
MY171853A MYPI2015001613A MYPI2015001613A MY171853A MY 171853 A MY171853 A MY 171853A MY PI2015001613 A MYPI2015001613 A MY PI2015001613A MY PI2015001613 A MYPI2015001613 A MY PI2015001613A MY 171853 A MY171853 A MY 171853A
Authority
MY
Malaysia
Prior art keywords
sphingomyelin
content
phosphatidyl inositol
containing supplement
salt
Prior art date
Application number
MYPI2015001613A
Other languages
English (en)
Inventor
Arai Youichi
Ishida Yuki
Shioya Yasushi
Original Assignee
Kao Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kao Corp filed Critical Kao Corp
Publication of MY171853A publication Critical patent/MY171853A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/688—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols both hydroxy compounds having nitrogen atoms, e.g. sphingomyelins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
MYPI2015001613A 2012-12-28 2013-12-27 Sphingomyelin-containing supplement MY171853A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2012288219 2012-12-28

Publications (1)

Publication Number Publication Date
MY171853A true MY171853A (en) 2019-11-05

Family

ID=51021385

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2015001613A MY171853A (en) 2012-12-28 2013-12-27 Sphingomyelin-containing supplement

Country Status (7)

Country Link
US (1) US9649322B2 (cg-RX-API-DMAC7.html)
EP (1) EP2939550B1 (cg-RX-API-DMAC7.html)
JP (2) JP5701371B2 (cg-RX-API-DMAC7.html)
CN (1) CN104883907B (cg-RX-API-DMAC7.html)
MY (1) MY171853A (cg-RX-API-DMAC7.html)
SG (1) SG11201505131UA (cg-RX-API-DMAC7.html)
WO (1) WO2014104316A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6484975B2 (ja) * 2014-09-24 2019-03-20 日油株式会社 グリセロリン脂質含有粉末および健康食品
EP4252744A4 (en) * 2020-11-30 2024-10-09 Kao Corporation SOLID COMPOSITION

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000139410A (ja) 1998-11-06 2000-05-23 Kansai Koso Kk 炊飯用カルシウム強化剤
US6441050B1 (en) * 2000-08-29 2002-08-27 Raj K. Chopra Palatable oral coenzyme Q liquid
ATE308548T1 (de) * 2000-11-07 2005-11-15 I R B Istituto Di Ricerche Bio Glycerophosphoinositol-derivate als cytosolic a2 phospholipase modulatoren
JP4568464B2 (ja) 2001-11-07 2010-10-27 雪印乳業株式会社 記憶障害予防治療剤
JP2004155682A (ja) 2002-11-05 2004-06-03 Dai Ichi Kogyo Seiyaku Co Ltd 錠剤用滑沢剤組成物
GB0322448D0 (en) * 2003-09-25 2003-10-29 Lamellar Therapeutics Ltd Using lamellar bodies to modify linear biological macro molecules
RU2480474C2 (ru) 2005-04-28 2013-04-27 Энзимотек Лтд. Смеси полярных липидов, их получение и применение
AU2006254548C1 (en) * 2005-05-31 2012-09-20 Arla Foods Amba Phosphatidylserine enriched milk fractions for the formulation of functional foods
JP2007246404A (ja) 2006-03-14 2007-09-27 Snow Brand Milk Prod Co Ltd 学習能向上剤
JP5179737B2 (ja) 2005-09-22 2013-04-10 雪印メグミルク株式会社 スフィンゴミエリン含有医薬
CN101272793B (zh) 2005-09-22 2011-02-09 雪印乳业株式会社 含有鞘髓磷脂的药物、饮食品或饲料
JP2008031148A (ja) 2006-07-05 2008-02-14 Kao Corp 筋力向上剤
CN101484157B (zh) 2006-07-05 2012-02-29 花王株式会社 肌肉力量提高剂
JP5208428B2 (ja) 2007-01-30 2013-06-12 雪印メグミルク株式会社 美肌剤
JP5281268B2 (ja) 2007-10-31 2013-09-04 花王株式会社 筋力向上剤
JP5465834B2 (ja) 2008-01-15 2014-04-09 雪印メグミルク株式会社 肝機能保護剤
JP5882559B2 (ja) * 2008-08-07 2016-03-09 花王株式会社 運動機能向上剤
US20100151037A1 (en) * 2008-08-07 2010-06-17 Yivan Jiang Method for the preparation of nanoparticles containing a poorly water-soluble pharmaceutically active compound
JP2010111608A (ja) 2008-11-05 2010-05-20 Kao Corp 筋損傷抑制剤
US8268360B2 (en) 2010-08-26 2012-09-18 Kao Corporation Motor function improver

Also Published As

Publication number Publication date
US9649322B2 (en) 2017-05-16
JP5701371B2 (ja) 2015-04-15
CN104883907A (zh) 2015-09-02
EP2939550B1 (en) 2018-11-21
EP2939550A4 (en) 2016-11-02
WO2014104316A1 (ja) 2014-07-03
SG11201505131UA (en) 2015-08-28
US20150342971A1 (en) 2015-12-03
JP2014141476A (ja) 2014-08-07
CN104883907B (zh) 2017-05-17
EP2939550A1 (en) 2015-11-04
JP2015083594A (ja) 2015-04-30

Similar Documents

Publication Publication Date Title
IN2015DN00123A (cg-RX-API-DMAC7.html)
MX2014011818A (es) Anticuerpos biespecificos contra inductor debil de la apoptosis relacionado con el tnf (tweak) humana e il17 humana y usos de los mismos.
MX360855B (es) Procedimiento para la preparación de una composición que comprende complejos metálicos en una matriz orgánica aceitosa.
MY179412A (en) Pyridine-2-amides useful as cb2 agonists
MY173521A (en) Trpv4 antagonists
MX2016004945A (es) Procesos para la preparacion de compuestos plaguicidas.
PH12015500900B1 (en) A stabilized pemetrexed formulation
IN2014DN06104A (cg-RX-API-DMAC7.html)
IN2014CN02970A (cg-RX-API-DMAC7.html)
NZ607149A (en) Galacto-oligosaccharide-containing composition and a method of producing it
PH12015500863A1 (en) Handleable calco-magnesian suspension
PH12013501859A1 (en) Indolecarboxamides and benzimidazolecarboxamides as insecticides and acaricides
TN2013000373A1 (en) Pharmaceutical formulation comprising inositol
PH12015501054A1 (en) Pyridiyloxyalkyl carboxamides and use thereof as endoparasiticides and nematicides
ZA201407010B (en) Process for the preparation of branched polybutadiene having high content of 1,4-cis units
IN2015DN03337A (cg-RX-API-DMAC7.html)
UA109460C2 (uk) N-гетарилметилпіразолілкарбоксаміди
WO2013184879A3 (en) Pumpable fat compositions
MY171853A (en) Sphingomyelin-containing supplement
MX2013008277A (es) Composicion liquida y acousa de bromfenaco, que tiene efectividad conservadora.
IN2014MN01492A (cg-RX-API-DMAC7.html)
NZ613887A (en) Antimicrobial activity enhancing agent
IN2013MU02035A (cg-RX-API-DMAC7.html)
UA82905U (ru) Состав рассола для огурцов
PH12014501092B1 (en) 5,5-dimethyl-2-propyl-hexahydro-2,4a-methanonaphthalene-1-one as a fragrance agent